Atlas Trials

High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma

Clinical trial NCT02416206 · COMPLETED

Trial details

NCT number
NCT02416206
Sponsor
Northside Hospital, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2015-04-27
Primary completion
2020-03-26
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.